CDH1 and gastric cancer: A recent study found that among patients not exclusively ascertained based on strict HDGC criteria, the cumulative incidence of gastric cancer for individuals with pathogenic CDH1 variants is significantly lower (42% at age 80 years) than what has been previously reported [6, 7].